Lifeboat Foundation

Mindfulness-based awareness training can help people learn to better control brain-computer interfaces. But a new study has found that a single guided mindfulness meditation exercise isn’t enough to boost performance. The findings, published in Frontiers in Human Neuroscience, suggest that a longer period of meditation is needed in order for people to experience observable improvements.

The authors of the research are interested in exploring the potential benefits of using mindfulness meditation as a training tool to improve the performance of brain-computer interfaces, which allow individuals to control machines or computers directly from their brain, bypassing the traditional neuromuscular pathway. These devices have the potential to greatly benefit people with conditions such as spinal cord injuries, stroke, and neurodegenerative diseases like amyotrophic lateral sclerosis (ALS).

Previous studies have shown that one of the most effective signals for brain-computer interface control is the sensorimotor rhythm produced in the primary sensorimotor areas during motor imagery. However, not everyone is able to effectively control brain-computer interfaces, with approximately 20% of the population being “BCI-inefficient” even with extensive training. Therefore, researchers are looking for ways to improve performance, and one potential method is through meditation.

Guy, a recognized industry thought leader, is the president of SmartSense, IoT solutions for the enterprise.

It’s no secret that healthcare systems exist at the intersection of financial risk and operational risk. Amid the market volatility of our current socioeconomic environment, the pressure is on hospitals, clinics and blood banks to maintain healthy profit margins that enable them to keep pace with rising demand for clinical care and prescription medications. The rate of U.S. spending on prescriptions is increasing at a rapid clip, and considering physician-administered drugs provide hospitals with high gross profits, investing in pharmaceutical services is a logical pathway to profitability.

However, severe pharmaceutical compliance regulations related to safety and efficacy—CDC, VFC, FDA, AABB and BOP—create a myriad of risk management issues for healthcare organizations to juggle. In the U.S., adverse drug effects are one of the most common medical errors. All it takes is one mismanaged medication to put a patient’s health at significant risk. And on a global scale, widespread vaccine hesitancy rooted in public skepticism has served as a critical roadblock to mitigating the spread of severe infectious diseases like Covid-19.

Summary: Researchers developed a machine learning algorithm, FoodProX, capable of predicting the degree of processing in food products.

The tool scores foods on a scale from zero (minimally or unprocessed) to 100 (highly ultra-processed). FoodProX bridges gaps in existing nutrient databases, providing higher resolution analysis of processed foods.

This development is a significant advancement for researchers examining the health impacts of processed foods.

Dr. Ralph W. Moss and son Ben discuss how the cultivation and care of the garden of tiny plants in your body can help you fight cancer.

For more information on cancer-fighting foods and supplements, please visit our website: https://www.themossreport.com.

Continue reading “Gut Health, Microbiome & Cancer — Can this garden of tiny plants in the gut help fight cancer?” »

Is the Quantum for Bio Program Director, at Wellcome Leap (https://wellcomeleap.org/our-team/elicakyoseva/), a $40M +$10M program focused on identifying, developing, and demonstrating biology and healthcare applications that will benefit from the quantum computers expected to emerge in the next 3–5 years.

Wellcome Leap was established with $300 million in initial funding from the Wellcome Trust, the UK charitable foundation, to accelerate discovery and innovation for the benefit of human health, focusing on build bold, unconventional programs and fund them at scale—specifically programs that target global human health challenges, with the goal of achieving breakthrough scientific and technological solutions.

Continue reading “Dr. Elica Kyoseva, Ph.D. — Quantum for Bio Program Director — Wellcome Leap” »

A new study finds a chemical formed when we digest a widely used sweetener is “genotoxic,” meaning it breaks up DNA. The chemical is also found in trace amounts in the sweetener itself, and the finding raises questions about how the sweetener may contribute to health problems.

At issue is sucralose, a widely used artificial sweetener sold under the trade name Splenda^®. Previous work by the same research team established that several fat-soluble compounds are produced in the gut after sucralose ingestion. One of these compounds is sucralose-6-acetate.

Our new work establishes that sucralose-6-acetate is genotoxic. We also found that trace amounts of sucralose-6-acetate can be found in off-the-shelf sucralose, even before it is consumed and metabolized.

A drug that was originally developed to treat diabetes and severe overweight might also help people with nicotine dependence, concludes new research from the University of Copenhagen.

Smoking is one of the greatest threats to public health. According to new data from the Danish Health Authority, 15,920 Danes die every year because of their addiction to cigarettes.

And 75% of smokers want to quit.

Diabetes — specifically type 2 diabetes— is becoming one of the most challenging health problems of the 21st century. By 2,025,380 million people worldwide are also expected to be diagnosed with diabetes.

In a recent study published in the Open Forum Infectious Diseases, researchers assess the resistance of uropathogenic Escherichia coli (UPEC) over time in adults who received uncomplicated urinary tract infections (uUTIs) outpatient care.

Study: Multi-drug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large U.S. integrated health care organization. Image Credit: 220 Selfmade studio / Shutterstock.com.